Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells

Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin Submitted June 3, 2009 ; accepted in final form August 9, 2009 Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2009-10, Vol.297 (4), p.R1127-R1135
Hauptverfasser: Wang, Zun-Yi, Wang, Peiqing, Bjorling, Dale E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R1135
container_issue 4
container_start_page R1127
container_title American journal of physiology. Regulatory, integrative and comparative physiology
container_volume 297
creator Wang, Zun-Yi
Wang, Peiqing
Bjorling, Dale E
description Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin Submitted June 3, 2009 ; accepted in final form August 9, 2009 Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We investigated whether mast cells participate in increase of cyclooxygenase-2 (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial cells to investigate cellular mechanisms underlying activation of PAR-2 resulting in increased COX-2 expression. We found that treatment of mice with CYP (150 mg/kg ip) increased COX-2 protein abundance in bladder urothelium/suburothelium 3, 6, and 24 h after CYP ( P < 0.01), and increased COX-2 protein abundance was prevented by treatment of mice with the mast cell stabilizer sodium cromolyn (10 mg/kg ip) for 4 consecutive days before CYP treatment. Incubation of freshly isolated mouse urothelium/suburothelium with a selective PAR-2 agonist, 2-furoyl-LIGRLO-amide (3 µM), also increased COX-2 protein abundance ( P < 0.05). We further demonstrated that 2-furoyl-LIGRLO-amide (3 µM) increased COX-2 mRNA expression and protein abundance in primary cultures of human urothelial cells ( P < 0.01), and the effects of PAR-2 activation were mediated primarily by the ERK1/2 MAP kinase pathway. These data indicate that there are functional interactions among mast cells, PAR-2 activation, and increased expression of COX-2 in bladder inflammation. urothelium; cyclophosphamide; mouse; inflammation; bladder Address for reprint requests and other correspondence: Z.-Y. Wang, Dept. of Surgical Sciences, School of Veterinary Medicine, Univ. of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53719 (e-mail: wangz{at}svm.vetmed.wisc.edu ).
doi_str_mv 10.1152/ajpregu.00310.2009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2763817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1869056221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-3c7dfe437757540d9eff2721236d038dd88402b0a53e8a204e75bac65bcd50c73</originalsourceid><addsrcrecordid>eNpVkVuL1DAYhoMo7rj6B7yQ4H3HHJv2RpDFEywIi16HTPK1zZBpatKu239v6gyrXgXyHvKSB6HXlOwpleydOU4J-mVPCC9XjJD2CdoVgVVUtOQp2hFe86qmtL1CL3I-EkIEF_w5uqJtrSRrxA71dzEAjh0-mTxjCyFkbEaHpxRnMBkqY2d_b2ZwOIGFaY6pYtiP2K42xPiw9jBuNobhoazJ2cdxk5eSHyB4E86lL9GzzoQMry7nNfrx6eP3my_V7bfPX28-3FZWcjZX3CrXgeBKSSUFcS10HVOMMl47whvnmkYQdiBGcmgMIwKUPBhby4N1kljFr9H7c--0HE7gLIxzMkFPyZ9MWnU0Xv-vjH7QfbzXTNW8oVvB20tBij8XyLM-xiWNZbNmrFWctFwWEzubbIo5J-geH6BEb2z0hY3-w0ZvbErozb_T_kYuMIphfzYMvh9--QR6GtbyoSH262Nh2aCFvqOUKf4bsWye0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229730935</pqid></control><display><type>article</type><title>Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Zun-Yi ; Wang, Peiqing ; Bjorling, Dale E</creator><creatorcontrib>Wang, Zun-Yi ; Wang, Peiqing ; Bjorling, Dale E</creatorcontrib><description>Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin Submitted June 3, 2009 ; accepted in final form August 9, 2009 Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We investigated whether mast cells participate in increase of cyclooxygenase-2 (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial cells to investigate cellular mechanisms underlying activation of PAR-2 resulting in increased COX-2 expression. We found that treatment of mice with CYP (150 mg/kg ip) increased COX-2 protein abundance in bladder urothelium/suburothelium 3, 6, and 24 h after CYP ( P &lt; 0.01), and increased COX-2 protein abundance was prevented by treatment of mice with the mast cell stabilizer sodium cromolyn (10 mg/kg ip) for 4 consecutive days before CYP treatment. Incubation of freshly isolated mouse urothelium/suburothelium with a selective PAR-2 agonist, 2-furoyl-LIGRLO-amide (3 µM), also increased COX-2 protein abundance ( P &lt; 0.05). We further demonstrated that 2-furoyl-LIGRLO-amide (3 µM) increased COX-2 mRNA expression and protein abundance in primary cultures of human urothelial cells ( P &lt; 0.01), and the effects of PAR-2 activation were mediated primarily by the ERK1/2 MAP kinase pathway. These data indicate that there are functional interactions among mast cells, PAR-2 activation, and increased expression of COX-2 in bladder inflammation. urothelium; cyclophosphamide; mouse; inflammation; bladder Address for reprint requests and other correspondence: Z.-Y. Wang, Dept. of Surgical Sciences, School of Veterinary Medicine, Univ. of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53719 (e-mail: wangz{at}svm.vetmed.wisc.edu ).</description><identifier>ISSN: 0363-6119</identifier><identifier>EISSN: 1522-1490</identifier><identifier>DOI: 10.1152/ajpregu.00310.2009</identifier><identifier>PMID: 19675284</identifier><identifier>CODEN: AJPRDO</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Bladder ; Cell Communication ; Cell culture ; Cells ; Cells, Cultured ; Cromolyn Sodium - pharmacology ; Cyclooxygenase 2 - genetics ; Cyclooxygenase 2 - metabolism ; Cyclophosphamide ; Cystitis - chemically induced ; Cystitis - enzymology ; Cystitis - immunology ; Disease Models, Animal ; Gene expression ; Humans ; Male ; Mast Cells - drug effects ; Mast Cells - immunology ; Mast Cells - metabolism ; Mice ; Mice, Inbred C57BL ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 - metabolism ; Oligopeptides - pharmacology ; Proteases ; Proteins ; Receptor, PAR-2 - agonists ; Receptor, PAR-2 - metabolism ; RNA, Messenger - metabolism ; Rodents ; Signal Transduction ; Time Factors ; Up-Regulation ; Urinary Bladder - enzymology ; Urinary Bladder - immunology ; Urothelium - enzymology ; Urothelium - immunology</subject><ispartof>American journal of physiology. Regulatory, integrative and comparative physiology, 2009-10, Vol.297 (4), p.R1127-R1135</ispartof><rights>Copyright American Physiological Society Oct 2009</rights><rights>Copyright © 2009 the American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-3c7dfe437757540d9eff2721236d038dd88402b0a53e8a204e75bac65bcd50c73</citedby><cites>FETCH-LOGICAL-c532t-3c7dfe437757540d9eff2721236d038dd88402b0a53e8a204e75bac65bcd50c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,3028,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19675284$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Zun-Yi</creatorcontrib><creatorcontrib>Wang, Peiqing</creatorcontrib><creatorcontrib>Bjorling, Dale E</creatorcontrib><title>Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells</title><title>American journal of physiology. Regulatory, integrative and comparative physiology</title><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><description>Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin Submitted June 3, 2009 ; accepted in final form August 9, 2009 Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We investigated whether mast cells participate in increase of cyclooxygenase-2 (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial cells to investigate cellular mechanisms underlying activation of PAR-2 resulting in increased COX-2 expression. We found that treatment of mice with CYP (150 mg/kg ip) increased COX-2 protein abundance in bladder urothelium/suburothelium 3, 6, and 24 h after CYP ( P &lt; 0.01), and increased COX-2 protein abundance was prevented by treatment of mice with the mast cell stabilizer sodium cromolyn (10 mg/kg ip) for 4 consecutive days before CYP treatment. Incubation of freshly isolated mouse urothelium/suburothelium with a selective PAR-2 agonist, 2-furoyl-LIGRLO-amide (3 µM), also increased COX-2 protein abundance ( P &lt; 0.05). We further demonstrated that 2-furoyl-LIGRLO-amide (3 µM) increased COX-2 mRNA expression and protein abundance in primary cultures of human urothelial cells ( P &lt; 0.01), and the effects of PAR-2 activation were mediated primarily by the ERK1/2 MAP kinase pathway. These data indicate that there are functional interactions among mast cells, PAR-2 activation, and increased expression of COX-2 in bladder inflammation. urothelium; cyclophosphamide; mouse; inflammation; bladder Address for reprint requests and other correspondence: Z.-Y. Wang, Dept. of Surgical Sciences, School of Veterinary Medicine, Univ. of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53719 (e-mail: wangz{at}svm.vetmed.wisc.edu ).</description><subject>Animals</subject><subject>Bladder</subject><subject>Cell Communication</subject><subject>Cell culture</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Cromolyn Sodium - pharmacology</subject><subject>Cyclooxygenase 2 - genetics</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Cyclophosphamide</subject><subject>Cystitis - chemically induced</subject><subject>Cystitis - enzymology</subject><subject>Cystitis - immunology</subject><subject>Disease Models, Animal</subject><subject>Gene expression</subject><subject>Humans</subject><subject>Male</subject><subject>Mast Cells - drug effects</subject><subject>Mast Cells - immunology</subject><subject>Mast Cells - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Oligopeptides - pharmacology</subject><subject>Proteases</subject><subject>Proteins</subject><subject>Receptor, PAR-2 - agonists</subject><subject>Receptor, PAR-2 - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Time Factors</subject><subject>Up-Regulation</subject><subject>Urinary Bladder - enzymology</subject><subject>Urinary Bladder - immunology</subject><subject>Urothelium - enzymology</subject><subject>Urothelium - immunology</subject><issn>0363-6119</issn><issn>1522-1490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVuL1DAYhoMo7rj6B7yQ4H3HHJv2RpDFEywIi16HTPK1zZBpatKu239v6gyrXgXyHvKSB6HXlOwpleydOU4J-mVPCC9XjJD2CdoVgVVUtOQp2hFe86qmtL1CL3I-EkIEF_w5uqJtrSRrxA71dzEAjh0-mTxjCyFkbEaHpxRnMBkqY2d_b2ZwOIGFaY6pYtiP2K42xPiw9jBuNobhoazJ2cdxk5eSHyB4E86lL9GzzoQMry7nNfrx6eP3my_V7bfPX28-3FZWcjZX3CrXgeBKSSUFcS10HVOMMl47whvnmkYQdiBGcmgMIwKUPBhby4N1kljFr9H7c--0HE7gLIxzMkFPyZ9MWnU0Xv-vjH7QfbzXTNW8oVvB20tBij8XyLM-xiWNZbNmrFWctFwWEzubbIo5J-geH6BEb2z0hY3-w0ZvbErozb_T_kYuMIphfzYMvh9--QR6GtbyoSH262Nh2aCFvqOUKf4bsWye0g</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Wang, Zun-Yi</creator><creator>Wang, Peiqing</creator><creator>Bjorling, Dale E</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20091001</creationdate><title>Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells</title><author>Wang, Zun-Yi ; Wang, Peiqing ; Bjorling, Dale E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-3c7dfe437757540d9eff2721236d038dd88402b0a53e8a204e75bac65bcd50c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Bladder</topic><topic>Cell Communication</topic><topic>Cell culture</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Cromolyn Sodium - pharmacology</topic><topic>Cyclooxygenase 2 - genetics</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Cyclophosphamide</topic><topic>Cystitis - chemically induced</topic><topic>Cystitis - enzymology</topic><topic>Cystitis - immunology</topic><topic>Disease Models, Animal</topic><topic>Gene expression</topic><topic>Humans</topic><topic>Male</topic><topic>Mast Cells - drug effects</topic><topic>Mast Cells - immunology</topic><topic>Mast Cells - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Oligopeptides - pharmacology</topic><topic>Proteases</topic><topic>Proteins</topic><topic>Receptor, PAR-2 - agonists</topic><topic>Receptor, PAR-2 - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Time Factors</topic><topic>Up-Regulation</topic><topic>Urinary Bladder - enzymology</topic><topic>Urinary Bladder - immunology</topic><topic>Urothelium - enzymology</topic><topic>Urothelium - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zun-Yi</creatorcontrib><creatorcontrib>Wang, Peiqing</creatorcontrib><creatorcontrib>Bjorling, Dale E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zun-Yi</au><au>Wang, Peiqing</au><au>Bjorling, Dale E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells</atitle><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>297</volume><issue>4</issue><spage>R1127</spage><epage>R1135</epage><pages>R1127-R1135</pages><issn>0363-6119</issn><eissn>1522-1490</eissn><coden>AJPRDO</coden><abstract>Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin Submitted June 3, 2009 ; accepted in final form August 9, 2009 Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We investigated whether mast cells participate in increase of cyclooxygenase-2 (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial cells to investigate cellular mechanisms underlying activation of PAR-2 resulting in increased COX-2 expression. We found that treatment of mice with CYP (150 mg/kg ip) increased COX-2 protein abundance in bladder urothelium/suburothelium 3, 6, and 24 h after CYP ( P &lt; 0.01), and increased COX-2 protein abundance was prevented by treatment of mice with the mast cell stabilizer sodium cromolyn (10 mg/kg ip) for 4 consecutive days before CYP treatment. Incubation of freshly isolated mouse urothelium/suburothelium with a selective PAR-2 agonist, 2-furoyl-LIGRLO-amide (3 µM), also increased COX-2 protein abundance ( P &lt; 0.05). We further demonstrated that 2-furoyl-LIGRLO-amide (3 µM) increased COX-2 mRNA expression and protein abundance in primary cultures of human urothelial cells ( P &lt; 0.01), and the effects of PAR-2 activation were mediated primarily by the ERK1/2 MAP kinase pathway. These data indicate that there are functional interactions among mast cells, PAR-2 activation, and increased expression of COX-2 in bladder inflammation. urothelium; cyclophosphamide; mouse; inflammation; bladder Address for reprint requests and other correspondence: Z.-Y. Wang, Dept. of Surgical Sciences, School of Veterinary Medicine, Univ. of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53719 (e-mail: wangz{at}svm.vetmed.wisc.edu ).</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>19675284</pmid><doi>10.1152/ajpregu.00310.2009</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-6119
ispartof American journal of physiology. Regulatory, integrative and comparative physiology, 2009-10, Vol.297 (4), p.R1127-R1135
issn 0363-6119
1522-1490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2763817
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Animals
Bladder
Cell Communication
Cell culture
Cells
Cells, Cultured
Cromolyn Sodium - pharmacology
Cyclooxygenase 2 - genetics
Cyclooxygenase 2 - metabolism
Cyclophosphamide
Cystitis - chemically induced
Cystitis - enzymology
Cystitis - immunology
Disease Models, Animal
Gene expression
Humans
Male
Mast Cells - drug effects
Mast Cells - immunology
Mast Cells - metabolism
Mice
Mice, Inbred C57BL
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - metabolism
Oligopeptides - pharmacology
Proteases
Proteins
Receptor, PAR-2 - agonists
Receptor, PAR-2 - metabolism
RNA, Messenger - metabolism
Rodents
Signal Transduction
Time Factors
Up-Regulation
Urinary Bladder - enzymology
Urinary Bladder - immunology
Urothelium - enzymology
Urothelium - immunology
title Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A37%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20mast%20cells%20and%20protease-activated%20receptor-2%20in%20cyclooxygenase-2%20expression%20in%20urothelial%20cells&rft.jtitle=American%20journal%20of%20physiology.%20Regulatory,%20integrative%20and%20comparative%20physiology&rft.au=Wang,%20Zun-Yi&rft.date=2009-10-01&rft.volume=297&rft.issue=4&rft.spage=R1127&rft.epage=R1135&rft.pages=R1127-R1135&rft.issn=0363-6119&rft.eissn=1522-1490&rft.coden=AJPRDO&rft_id=info:doi/10.1152/ajpregu.00310.2009&rft_dat=%3Cproquest_pubme%3E1869056221%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229730935&rft_id=info:pmid/19675284&rfr_iscdi=true